- Home
- PRT vs MDAI Comparison
PRT vs MDAI Comparison
Compare PRT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRT
- MDAI
- Stock Information
- Founded
- PRT 2017
- MDAI 2013
- Country
- PRT United States
- MDAI United States
- Employees
- PRT N/A
- MDAI N/A
- Industry
- PRT Oil & Gas Production
- MDAI Medical/Dental Instruments
- Sector
- PRT Energy
- MDAI Health Care
- Exchange
- PRT Nasdaq
- MDAI Nasdaq
- Market Cap
- PRT 47.6M
- MDAI 51.5M
- IPO Year
- PRT N/A
- MDAI N/A
- Fundamental
- Price
- PRT $4.08
- MDAI $2.12
- Analyst Decision
- PRT
- MDAI Strong Buy
- Analyst Count
- PRT 0
- MDAI 2
- Target Price
- PRT N/A
- MDAI $4.75
- AVG Volume (30 Days)
- PRT 29.4K
- MDAI 455.5K
- Earning Date
- PRT 08-08-2025
- MDAI 08-11-2025
- Dividend Yield
- PRT 10.63%
- MDAI N/A
- EPS Growth
- PRT 6.25
- MDAI N/A
- EPS
- PRT 0.45
- MDAI N/A
- Revenue
- PRT $6,430,197.00
- MDAI $29,962,000.00
- Revenue This Year
- PRT N/A
- MDAI N/A
- Revenue Next Year
- PRT N/A
- MDAI $56.05
- P/E Ratio
- PRT $9.06
- MDAI N/A
- Revenue Growth
- PRT 5.12
- MDAI 55.21
- 52 Week Low
- PRT $3.26
- MDAI $0.82
- 52 Week High
- PRT $4.63
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- PRT 56.76
- MDAI 67.16
- Support Level
- PRT $3.90
- MDAI $1.97
- Resistance Level
- PRT $4.15
- MDAI $2.28
- Average True Range (ATR)
- PRT 0.11
- MDAI 0.16
- MACD
- PRT 0.01
- MDAI 0.01
- Stochastic Oscillator
- PRT 62.07
- MDAI 82.81
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.